PRIMECAP Management trim BioMarin Pharmaceutical Inc.
PRIMECAP Management trim $1.5B of disclosed value in BioMarin Pharmaceutical Inc..
Signal
Investor Move
Action
Trim
Capital
$1.5B disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.